MenoSolve plus Probiotics
On sale on the US market (according to the DSLD)
Greens First Female, food supplement from the US market
MenoSolve plus Probiotics (Greens First Female), a food supplement au code-barres 819354001621, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. Doses of niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 175 mg a day according to the label (at most 1 serving a day), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Chrome: up to 120 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Greens First Female
- Barcode
- 819354001621
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Hypromellose, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin E | Vitamin | 175 mg |
| Niacin | Vitamin | 20 mg |
| Pantothenic Acid | Vitamin | 10 mg |
| Magnesium | Mineral | 50 mg |
| Chromium | Mineral | 120 µg |
| Horseradish Tree, Powder (Moringa oleifera) | Plant | 220 mg |
| Red Clover, Powder (Trifolium pratense) | Plant | 220 mg |
| Sensoril (Withania somnifera) | Plant | 75 mg |
| Cnidium, Powder (Cnidium monnieri) | Plant | 50 mg |
| Guggul Gum Resin powder (Commiphora mukul) | Plant | 20 mg |
| Royal Jelly, Powder | Ingredient of animal origin | 12.5 mg |
| Probiotic Blend Complex | Blend | 12 mg |
| Lactobacillus acidophilus | Micro-organism | not stated |
| Bifidobacterium breve | Micro-organism | not stated |
| Lactobacillus casei | Micro-organism | not stated |
| Lactobacillus rhamnosus | Micro-organism | not stated |
| Bifidobacterium longum | Micro-organism | not stated |
| Bifidobacterium bifidum | Micro-organism | not stated |
| Bifidobacterium infantis | Micro-organism | not stated |
| Lactobacillus reuteri | Micro-organism | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: MenoSolve
Entered into DSLD on 21 September 2018. Withdrawn from the US market on 9 March 2023 (according to the DSLD).- Active ingredient added : Moringa (220 mg)
- Active ingredient added : Red Clover flower powder (100 mg)
- Active ingredient removed : Horseradish Tree, Powder (220 mg)
- Active ingredient removed : Red Clover, Powder (220 mg)
- Same quantity, different name: Bifidobacteria infantis in this version; Bifidobacterium infantis on the displayed label (quantity not stated)
- Same quantity, different name: Cnidium monnieri fruit powder in this version; Cnidium, Powder on the displayed label (50 mg)
- Same quantity, different name: Sensoril Ashwagandha root and leaf extract in this version; Sensoril on the displayed label (75 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sensoril
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Greens First Female
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “MenoSolve plus Probiotics (Greens First Female): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/819354001621-menosolve-plus-probiotics-greens-first-female, updated 22 August 2024.